These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 21382917

  • 1. Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.
    Lee YH, Lee HS, Choi SJ, Dai Ji J, Song GG.
    Lupus; 2011 May; 20(6):636-40. PubMed ID: 21382917
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 3. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.
    Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
    [Abstract] [Full Text] [Related]

  • 4. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade.
    Tse KC, Lam MF, Tang SC, Tang CS, Chan TM.
    Lupus; 2007 Dec; 16(1):46-51. PubMed ID: 17283585
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 7. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
    Fei Y, Wu Q, Zhang W, Chen H, Hou Y, Xu D, Li M, Zhang X, Zhao Y, Zeng X, Zhang F.
    Clin Exp Rheumatol; 2013 Apr; 31(1):62-8. PubMed ID: 22935463
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 9. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.
    Hannah J, Casian A, D'Cruz D.
    Autoimmun Rev; 2016 Jan; 15(1):93-101. PubMed ID: 26427983
    [Abstract] [Full Text] [Related]

  • 10. Effect of Tacrolimus vs Intravenous Cyclophosphamide on Complete or Partial Response in Patients With Lupus Nephritis: A Randomized Clinical Trial.
    Zheng Z, Zhang H, Peng X, Zhang C, Xing C, Xu G, Fu P, Ni Z, Chen J, Xu Z, Zhao MH, Li S, Huang X, Miao L, Chen X, Liu B, He Y, Li J, Liu L, Kadeerbai H, Liu Z, Liu Z.
    JAMA Netw Open; 2022 Mar 01; 5(3):e224492. PubMed ID: 35353167
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
    Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J.
    Lupus; 2012 Aug 01; 21(9):1025-35. PubMed ID: 22570338
    [Abstract] [Full Text] [Related]

  • 12. A meta-analysis of randomized controlled trials comparing tacrolimus with intravenous cyclophosphamide in the induction treatment for lupus nephritis.
    Deng J, Huo D, Wu Q, Yang Z, Liao Y.
    Tohoku J Exp Med; 2012 Aug 01; 227(4):281-8. PubMed ID: 22820853
    [Abstract] [Full Text] [Related]

  • 13. Success using tacrolimus in patients with proliferative and membranous lupus nephritis and refractory proteinuria.
    Gordon S, Denunzio T, Uy A.
    Hawaii J Med Public Health; 2013 Sep 01; 72(9 Suppl 4):18-23. PubMed ID: 24052913
    [Abstract] [Full Text] [Related]

  • 14. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
    Chen W, Tang X, Liu Q, Chen W, Fu P, Liu F, Liao Y, Yang Z, Zhang J, Chen J, Lou T, Fu J, Kong Y, Liu Z, Fan A, Rao S, Li Z, Yu X.
    Am J Kidney Dis; 2011 Feb 01; 57(2):235-44. PubMed ID: 21177013
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2014 Jul 01; 24(4):618-25. PubMed ID: 24252014
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul 01; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China.
    Kim S, Reen Ooi AY, Stephens T, Jiang H.
    J Comp Eff Res; 2019 Oct 01; 8(13):1125-1141. PubMed ID: 31580156
    [Abstract] [Full Text] [Related]

  • 20. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Kronbichler A, Neumann I, Mayer G.
    Nephrol Dial Transplant; 2016 Oct 01; 31(10):1572-6. PubMed ID: 27591329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.